249 related articles for article (PubMed ID: 15023708)
21. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
[TBL] [Abstract][Full Text] [Related]
22. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
[TBL] [Abstract][Full Text] [Related]
23. Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
Stapleton JA; Sutherland G
Addiction; 2011 Apr; 106(4):824-32. PubMed ID: 21205043
[TBL] [Abstract][Full Text] [Related]
24. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
[TBL] [Abstract][Full Text] [Related]
25. The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence.
Ashare RL; Wileyto EP; Perkins KA; Schnoll RA
J Addict Med; 2013; 7(4):249-54. PubMed ID: 23669629
[TBL] [Abstract][Full Text] [Related]
26. Randomised controlled trial of nasal nicotine spray in smoking cessation.
Sutherland G; Stapleton JA; Russell MA; Jarvis MJ; Hajek P; Belcher M; Feyerabend C
Lancet; 1992 Aug; 340(8815):324-9. PubMed ID: 1353803
[TBL] [Abstract][Full Text] [Related]
27. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
28. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
[TBL] [Abstract][Full Text] [Related]
29. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
[TBL] [Abstract][Full Text] [Related]
30. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
31. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
[TBL] [Abstract][Full Text] [Related]
32. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
33. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
34. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
[TBL] [Abstract][Full Text] [Related]
35. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
36. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.
Blondal T; Gudmundsson LJ; Olafsdottir I; Gustavsson G; Westin A
BMJ; 1999 Jan; 318(7179):285-8. PubMed ID: 9924052
[TBL] [Abstract][Full Text] [Related]
37. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
Croghan GA; Sloan JA; Croghan IT; Novotny P; Hurt RD; DeKrey WL; Mailliard JA; Ebbert LP; Swan DK; Walsh DJ; Wiesenfeld M; Levitt R; Stella P; Johnson PA; Tschetter LK; Loprinzi C
Nicotine Tob Res; 2003 Apr; 5(2):181-7. PubMed ID: 12745490
[TBL] [Abstract][Full Text] [Related]
38. Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation.
Caldwell BO; Adamson SJ; Crane J
Nicotine Tob Res; 2014 Oct; 16(10):1356-64. PubMed ID: 24872027
[TBL] [Abstract][Full Text] [Related]
39. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
40. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
